SCHEMBL3847428

SCHEMBL3847428

Cc1n[nH]cc1-c1ccc2ncnc(N3CCN(Cc4ccccc4)CC3)c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.58
BACE1 P56817 4/20 0.58
ALDH1A1 P00352 11/20 0.53
CYP1A2 P05177 9/20 0.53
CYP3A4 P08684 9/20 0.53
KMT2A Q03164 8/20 0.53
CLK4 Q9HAZ1 7/20 0.53
TSHR P16473 7/20 0.53
HIF1A Q16665 7/20 0.53
MEN1 O00255 7/20 0.53
LMNA P02545 6/20 0.53
MAPK1 P28482 6/20 0.53
USP2 O75604 4/20 0.53
CYP2C19 P33261 8/20 0.52
CYP2D6 P10635 3/20 0.52
HSD17B10 Q99714 2/20 0.52
KDM4E B2RXH2 4/20 0.50
HPGD P15428 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
GAA P10253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854867 0.91 AURKA (0.60) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3852832 0.90 ACHE (0.55) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3846990 0.86 ACHE (0.54) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3852842 0.86 KIT (0.42) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3856383 0.85 HTT (0.65) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3847066 0.84 CYP1A2 (0.61) ALDH1A1CYP1A2CYP3A4KMT2ACLK4
SCHEMBL3851339 0.84 CYP3A4 (0.67) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3846032 0.83 HTT (0.52) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL30734213 0.82 ACHE (0.57) ACHEBACE1ALDH1A1CYP1A2CYP3A4
SCHEMBL3847901 0.82 CYP1A2 (0.53) ALDH1A1CYP1A2CYP3A4KMT2ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed